SPP1 as a central mediator in the tumor microenvironment: Orchestrating cellular crosstalk, immune evasion, and therapy resistance
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-04 · 1881 (2) · 189555
DOI: 10.1016/j.bbcan.2026.189555 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-04. Verfasst von Linhong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Key Medical Laboratory of Tumor M…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Drug Resistance, Neoplasm, Neoplasms, Osteopontin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Secreted phosphoprotein-1 (SPP1) is a multifaceted glycoprotein that extends beyond its role as a mere component of the extracellular matrix, functioning instead as a pivotal signaling hub within the tumor microenvironment (TME). This review synthesizes current evidence regarding how SPP1 orchestrates a complex cellular network by mediating bidirectional crosstalk between cancer cells and key stromal components including cancer-associated fibroblasts, tumor-associated macrophages, endothelial cells, and lymphocytes. We elucidate how these interactions drive TME reprogramming, facilitating processes such as extracellular matrix remodeling, angiogenesis, immune evasion, and the establishment of therapeutic resistance to both chemotherapy and immunotherapy. Furthermore, we assess emerging therapeutic strategies targeting SPP1 such as aptamers and antibodies, highlighting their preclinical efficacy alongside the translational challenges that must be addressed. Ultimately, targeting the SPP1-mediated network represents a promising approach for dismantling the pro-tumorigenic TME and enhancing cancer treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou 450052, Henan, Ch…
- Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, Henan, China; College of Public Health, Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Key Medical Laboratory…
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, L., Cheng, Y., Li, J., Liao, R., Gao, X., & Du, R. (2026). SPP1 as a central mediator in the tumor microenvironment: Orchestrating cellular crosstalk, immune evasion, and therapy resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(2), 189555. https://doi.org/10.1016/j.bbcan.2026.189555
Vancouver
Wang L, Cheng Y, Li J, Liao R, Gao X, Du R. SPP1 as a central mediator in the tumor microenvironment: Orchestrating cellular crosstalk, immune evasion, and therapy resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(2):189555. doi:10.1016/j.bbcan.2026.189555
BibTeX
@article{Wang2026,
author = {Wang, Linhong and Cheng, Yachen and Li, Jialu and Liao, Rulan and Gao, Xiaohui and Du, Renle},
title = {SPP1 as a central mediator in the tumor microenvironment: Orchestrating cellular crosstalk, immune evasion, and therapy resistance},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {2},
pages = {189555},
doi = {10.1016/j.bbcan.2026.189555}
}
EUVIMED